Cargando…

Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents

INTRODUCTION: Recurrent extreme hyperferritinemia (ferritin >10,000 ng/mL) was noted in 4 critically ill adolescents prior to death, though this association has not previously been described. METHODS: A retrospective review of the medical records of 4 critically ill adolescents with recurrent ext...

Descripción completa

Detalles Bibliográficos
Autor principal: Baird, John Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964169/
https://www.ncbi.nlm.nih.gov/pubmed/35360192
http://dx.doi.org/10.1155/2022/6207417
_version_ 1784678152074690560
author Baird, John Scott
author_facet Baird, John Scott
author_sort Baird, John Scott
collection PubMed
description INTRODUCTION: Recurrent extreme hyperferritinemia (ferritin >10,000 ng/mL) was noted in 4 critically ill adolescents prior to death, though this association has not previously been described. METHODS: A retrospective review of the medical records of 4 critically ill adolescents with recurrent extreme hyperferritinemia and systemic inflammation was performed to identify additional common epidemiologic factors. RESULTS: Systemic inflammation was characterized as cytokine storm syndrome in 2 patients and hemophagocytic lymphohistiocytosis in 2 patients. Episodes of extreme hyperferritinemia were noted on at least 2 different dates in all patients; these episodes (n = 10) were separated by an interval of 2 weeks to several months and were usually (in 8 of 10 episodes) associated with the onset or worsening of multiple organ dysfunction syndrome. Death occurred within 2 weeks of the onset of an episode of recurrent extreme hyperferritinemia. Lymphocytopenia and cachexia were noted in all patients. CONCLUSIONS: Recurrent extreme hyperferritinemia—often with multiple organ dysfunction syndrome—was noted in 4 adolescents with systemic inflammation who did not survive their critical illness. Recurrent extreme hyperferritinemia may be a novel biomarker of increased mortality in patients with the syndrome of persistent inflammation, immunosuppression, and catabolism.
format Online
Article
Text
id pubmed-8964169
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89641692022-03-30 Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents Baird, John Scott Int J Inflam Research Article INTRODUCTION: Recurrent extreme hyperferritinemia (ferritin >10,000 ng/mL) was noted in 4 critically ill adolescents prior to death, though this association has not previously been described. METHODS: A retrospective review of the medical records of 4 critically ill adolescents with recurrent extreme hyperferritinemia and systemic inflammation was performed to identify additional common epidemiologic factors. RESULTS: Systemic inflammation was characterized as cytokine storm syndrome in 2 patients and hemophagocytic lymphohistiocytosis in 2 patients. Episodes of extreme hyperferritinemia were noted on at least 2 different dates in all patients; these episodes (n = 10) were separated by an interval of 2 weeks to several months and were usually (in 8 of 10 episodes) associated with the onset or worsening of multiple organ dysfunction syndrome. Death occurred within 2 weeks of the onset of an episode of recurrent extreme hyperferritinemia. Lymphocytopenia and cachexia were noted in all patients. CONCLUSIONS: Recurrent extreme hyperferritinemia—often with multiple organ dysfunction syndrome—was noted in 4 adolescents with systemic inflammation who did not survive their critical illness. Recurrent extreme hyperferritinemia may be a novel biomarker of increased mortality in patients with the syndrome of persistent inflammation, immunosuppression, and catabolism. Hindawi 2022-03-22 /pmc/articles/PMC8964169/ /pubmed/35360192 http://dx.doi.org/10.1155/2022/6207417 Text en Copyright © 2022 John Scott Baird. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Baird, John Scott
Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title_full Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title_fullStr Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title_full_unstemmed Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title_short Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents
title_sort mortality associated with recurrent extreme hyperferritinemia in critically ill adolescents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964169/
https://www.ncbi.nlm.nih.gov/pubmed/35360192
http://dx.doi.org/10.1155/2022/6207417
work_keys_str_mv AT bairdjohnscott mortalityassociatedwithrecurrentextremehyperferritinemiaincriticallyilladolescents